Pyxis Oncology, Inc. Common Stock (PYXS) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for PYXS. 13F holdings as of 2026-06-30.
In 13F filings for the quarter ended June 30, 2026, 74 institutions reported holding PYXS, with 34.2 million shares worth $101.1 million in aggregate.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| Gordonmd Global Investments | 10,024,909 | $30M | INCREASED |
| Pfizer | 7,032,770 | $19M | UNCHANGED |
| Laurion Capital Management | 4,900,888 | $15M | DECREASED |
| Vanguard | 2,400,225 | $7M | INCREASED |
| Atle Fund Management AB | 966,459 | $3M | INCREASED |
Full institutional holdings, insider history, and congressional trades for Pyxis Oncology, Inc. Common Stock on SentiSense.